Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
![Foto de Raffaele](/img/nophoto.png)
Raffaele
Strippoli
Publicaciones en las que colabora con Raffaele Strippoli (16)
2024
-
Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression
Cancers, Vol. 16, Núm. 4, pp. 807
-
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Cancer Letters, Vol. 585
-
Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype
Frontiers in Cellular and Infection Microbiology, Vol. 14
-
Metal-based nanoparticles in cancer therapy: Exploring photodynamic therapy and its interplay with regulated cell death pathways
International Journal of Pharmaceutics, Vol. 649
2023
-
Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective (Cell & Bioscience, (2023), 13, 1, (44), 10.1186/s13578-023-00986-9)
Cell and Bioscience
-
Editorial: Autophagy modulation in cancer treatment utilizing nanomaterials and nanocarriers
Frontiers in Oncology
-
Metal-based Nanoparticles in Cancer Therapy: Exploring Photodynamic Therapy and its Interplay with Regulated Cell Death Pathways (Pre-Proof)
International Journal of Pharmaceutics, pp. 123622
-
Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective
Cell and Bioscience, Vol. 13, Núm. 1
2021
-
Autophagy and the lysosomal system in cancer
Cells, Vol. 10, Núm. 10
-
Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
Frontiers in Pharmacology
-
Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
Frontiers in Immunology, Vol. 12
2020
-
Nanomaterials as inhibitors of epithelial mesenchymal transition in cancer treatment
Cancers, Vol. 12, Núm. 1
-
Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment
Frontiers in Pharmacology, Vol. 11
2019
-
Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches
Oxidative medicine and cellular longevity
-
Sestrins as a therapeutic bridge between ros and autophagy in cancer
Cancers, Vol. 11, Núm. 10
-
Sestrins at the interface of ROS control and autophagy regulation in health and disease
Oxidative Medicine and Cellular Longevity, Vol. 2019